Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Other Accumulated Expenses (2016 - 2020)

Rockwell Medical's Other Accumulated Expenses history spans 10 years, with the latest figure at $57000.0 for Q1 2020.

  • For Q1 2020, Other Accumulated Expenses fell 65.8% year-over-year to $57000.0; the TTM value through Mar 2020 reached $57000.0, down 65.8%, while the annual FY2019 figure was $104000.0, 75.04% down from the prior year.
  • Other Accumulated Expenses reached $57000.0 in Q1 2020 per RMTI's latest filing, down from $104000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.3 million in Q4 2017 to a low of $57000.0 in Q1 2020.
  • Average Other Accumulated Expenses over 5 years is $797856.4, with a median of $423334.0 recorded in 2018.
  • Peak YoY movement for Other Accumulated Expenses: grew 17.14% in 2016, then plummeted 82.07% in 2018.
  • A 5-year view of Other Accumulated Expenses shows it stood at $2.0 million in 2016, then increased by 15.4% to $2.3 million in 2017, then tumbled by 82.07% to $416668.0 in 2018, then tumbled by 75.04% to $104000.0 in 2019, then crashed by 45.19% to $57000.0 in 2020.
  • Per Business Quant, the three most recent readings for RMTI's Other Accumulated Expenses are $57000.0 (Q1 2020), $104000.0 (Q4 2019), and $270000.0 (Q3 2019).